Nucleix announces $22 million in funding, advancements in lung cancer detection program
The Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection
Source: calcalistech.com
Lung Epicheck News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lung Epicheck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lung Epicheck Today - Breaking & Trending Today
Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients
Share: Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC) Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress. The first abstract titled, "Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance," shows the results of a pilot performed at Radboud Universi...
Source: benzinga.com
Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients - Press Release
Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC) Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress. The first abstract titled, “Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance,” shows the results of a pilot performed at Radboud University ...
Source: wiredprnews.com
Nucleix : Establishes Collaborative Research and License Agreement with MD Anderson to Develop Methylation Assays to Assess Lung Cancer Patients
Nucleix : Establishes Collaborative Research and License Agreement with MD Anderson to Develop Methylation Assays to Assess Lung Cancer Patients 06/03/2021 | 08:10am EDT Send by mail : Message : Agreement to build upon research and technical expertise in characterizing methylation patterns in lung cancer Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has entered into a collaborative research and license agreement with The University of Texas MD Anderson Cancer Center to evaluate and develop methylation assays focused on lung cancer, using ...
Source: marketscreener.com